Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...

Neoadjuvant chemotherapy for advanced ovarian cancer was initially administered as an alternative treatment for patients not suitable for primary debulking surgery (PDS) because of unresectable ...

Primary debulking surgery for advanced epithelial ovarian cancer with isolated enlarged para-aortic lymph node by robotic transumbilical single port approach. Low pressure laparoscopic procedure ...

One of the most important factors in how well a patient with ovarian cancer will do is based on their initial surgery and how much of their disease is/was removed at that time. Patients who undergo an ...

AI models outperform traditional statistics in predicting post-complete cytoreduction outcomes in ovarian cancer patients ... application in predicting debulking outcomes. Despite these challenges ...